ArticleBMC cardiovascular disorders2026
Development and validation of a risk prediction model for in-hospital mortality among patients with acute myocardial infarction complicated by ventricular arrhythmia.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWith the widespread adoption of percutaneous coronary intervention (PCI), patients experiencing acute myocardial infarction (AMI) complicated by ventricular arrhythmia (VA) continue to encounter a significant risk of in-hospital mortality. The predictive accuracy of existing scoring systems for this specific high-risk subgroup requires enhancement, as there is a notable absence of specialized predictive tools that integrate electrophysiological characteristics (such as fragmented QRS waves and electrical storms) with clinical metabolic indicators. This study aims to identify the independent factors influencing in-hospital mortality among patients with AMI complicated by VA, develop and validate a Nomogram prediction model, and provide a reference for early clinical risk stratification.
methodsIn this study, a retrospective cohort design was employed, encompassing patients diagnosed with AMI complicated by VA who were admitted to the Department of Cardiology at a tertiary first-class hospital in Anhui Province between November 2020 and October 2025. A comprehensive dataset comprising 38 variables was collected, including demographic information, clinical evaluations, laboratory tests, and electrocardiogram (ECG) physiological indices. To address data dimensionality and identify key variables, the Least Absolute Shrinkage and Selection Operator (LASSO) regression was utilized. Subsequently, multivariate logistic regression analysis was conducted to ascertain the independent factors influencing in-hospital mortality. A nomogram model was developed using R software, with its performance assessed through receiver operating characteristic (ROC) curve analysis, calibration curve, and decision curve analysis (DCA). Rigorous internal validation was performed using the bootstrap method with 1,000 resamples and 10-fold cross-validation.
resultsAmong the 236 patients studied, 62 individuals (26.3%) succumbed during hospitalization. The LASSO regression analysis identified eight significant predictor variables: heart failure, modified shock index, TIMI flow grade, abnormal blood potassium levels, abnormal blood creatinine levels, late onset of VA, electrical storm, and fragmented QRS waves. The nomogram model, developed based on these factors, demonstrated excellent discrimination, with an area under the curve (AUC) of 0.845 (95% confidence interval [CI]: 0.783–0.908), surpassing the GRACE score’s AUC of 0.740 (95% CI: 0.670–0.811) and the TIMI risk score’s AUC of 0.723 (95% CI: 0.656–0.708). Following bootstrap validation, the nomogram’s concordance index (C-index) was 0.820, and the AUC from 10-fold cross-validation was 0.849, indicating that the model is not overfitted. The calibration curve demonstrates a high degree of agreement between the predicted probabilities and the actual incidence rates (Spiegelhalter’s Z test, P = 0.627). The DCA curve further confirms that the model provides substantial clinical net benefit within a threshold probability range of 0.07 to 0.99.
conclusionIn this study, a risk prediction model for in-hospital mortality among patients with acute myocardial infarction complicated by ventricular arrhythmia was developed and validated. The model incorporates electrophysiological characteristics and biochemical markers, demonstrating high predictive accuracy and generalizability. This model serves as a valuable tool for clinicians in the early identification of patients at extremely high risk, facilitating the formulation of targeted intensive intervention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.